Kirsten Grønbæk

Kirsten Grønbæk

Clinical Professor

Member of:

  • Internal Medicine: Haematology


Publication year:
All
81 - 90 out of 169Page size: 10
  1. 2019
  2. Published

    Epigenetic therapy in hematological cancers

    Dimopoulos, K. & Grønbæk, Kirsten, 2019, In: A P M I S. Acta Pathologica, Microbiologica et Immunologica Scandinavica. 127, 5, p. 316-328 13 p.

    Research output: Contribution to journal › Review › Research › peer-review

  3. Published

    Expression of CRBN, IKZF1, and IKZF3 does not predict lenalidomide sensitivity and mutations in the cereblon pathway are infrequent in multiple myeloma

    Dimopoulos, K., Fibiger Munch-Petersen, H., Winther Eskelund, C., Sjö, Lene Dissing, Ralfkiær, E., Gimsing, P. & Grønbæk, Kirsten, 2019, In: Leukemia and Lymphoma. 60, 1, p. 180-188

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults: Recommendations for Genetic Diagnosis, Clinical Management and Follow-up

    Baliakas, P., Tesi, B., Wartiovaara-kautto, U., Stray-pedersen, A., Friis, L. S., Dybedal, I., Hovland, R., Jahnukainen, K., Raaschou-Jensen, K., Ljungman, P., Rustad, C. F., Lautrup, C. K., Kilpivaara, O., Kittang, A. O., Grønbæk, Kirsten, Cammenga, J., Hellström-lindberg, E. & Andersen, M. K., 2019, In: HemaSphere. 3, 6, p. 1-10 e321.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Oral vitamin C supplementation to patients with myeloid cancer on azacitidine treatment: Normalization of plasma vitamin C induces epigenetic changes

    Gillberg, Linn, mxz703, mxz703, Nasif, A., Ohtani, H., Madaj, Z., Hansen, Jakob Werner, Rapin, N., Mogensen, J. B., Liu, M., Dufva, I. H., Lykkesfeldt, Jens, Hajkova, P., Jones, P. A. & Grønbæk, Kirsten, 17 Oct 2019, In: Clinical Epigenetics. 11, 1, p. 143-153 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Increased neonatal level of arginase 2 in cases of childhood acute lymphoblastic leukemia implicates immunosuppression in the etiology

    Nielsen, A. B., Zhou, M., de Smith, A. J., Wang, R., McCoy, L., Hansen, H., Morimoto, L., Grønbæk, Kirsten, Johansen, Christoffer, Kogan, S. C., Metayer, C., Bracci, P. M., Ma, X. & Wiemels, J. L., Nov 2019, In: Haematologica. 104, 11, p. e514-e516 3 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. 2020
  8. Published

    Activation of a subset of evolutionarily young transposable elements and innate immunity are linked to clinical responses to 5-azacytidine

    Ohtani, H., mxz703, mxz703, Helbo, A. S., Gillberg, Linn, Liu, M., Zhou, W., Ungerstedt, J., Hellström-Lindberg, E., Sun, W., Liang, G., Jones, P. A. & Grønbæk, Kirsten, 2020, In: Cancer Research. 80, 12, p. 2441-2450 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma

    Urup, T., Gillberg, Linn, Kaastrup, K., Lü, M. J. S., Michaelsen, Signe Regner, Andrée Larsen, V., Christensen, I. J., Broholm, H., Lassen, Ulrik Niels, Grønbæk, Kirsten & Poulsen, H. S., 2020, In: Molecular Oncology. 14, 5, p. 964-973

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Cell‐of‐origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B‐cell lymphoma

    Abdulla, M., Hollander, P., Pandzic, T., Mansouri, L., Ednersson, S. B., Andersson, P., Hultdin, M., Fors, M., Erlanson, M., Degerman, S., Petersen, H. M., Asmar, F., Grønbæk, Kirsten, Enblad, G., Cavelier, L., Rosenquist, R. & Amini, R., 2020, In: American Journal of Hematology. 95, 1, p. 57-67

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Clinical impact of clonal hematopoiesis in patients with lymphoma undergoing ASCT: a national population-based cohort study

    Husby, S., Favero, F., Nielsen, C., Sørensen, B. S., Bæch, J., Grell, K., Hansen, J. W., Rodriguez-Gonzalez, F. G., Haastrup, E. K., Fischer-Nielsen, A., Andersen, P., Arboe, B., Sækmose, S. G., Hansen, P. B., Christiansen, I., Clasen-Linde, E., Meldgaard, L., Ebbesen, L. H., Segel, E. K., Josefsson, P. & 6 others, Thorsgaard, M., El-Galaly, T. C., Brown, Peter de Nully, Weischenfeldt, Joachim Lütken, Larsen, T. S. & Grønbæk, Kirsten, 2020, In: Leukemia. 34, p. 3256-3268 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    Clonal hematopoiesis evolves from pretreatment clones and stabilizes after end of chemotherapy in patients with MCL

    Eskelund, C. W., Husby, Simon, Favero, Francesco, Klausen, T. W., Rodriguez Gonzalez, Francisco G, Kolstad, A., Pedersen, L. B., Räty, R. K., Geisler, C. H., Jerkeman, M., Weischenfeldt, Joachim Lütken & Grønbæk, Kirsten, 2020, In: Blood. 135, 22, p. 2000-2004

    Research output: Contribution to journal › Comment/debate › Research › peer-review

Previous 1...5 6 7 8 9 10 11 12 ...17 Next

ID: 37722667